Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Apr;81(4):1036–1041. doi: 10.1172/JCI113414

Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat.

J E Greenwald 1, M Sakata 1, M L Michener 1, S D Sides 1, P Needleman 1
PMCID: PMC329628  PMID: 2965162

Abstract

Atriopeptin (AP), a natriuretic-diuretic and vasodilatory peptide, is synthesized and secreted from mammalian atria. The definitive role of this peptide on cardiovascular physiology and pathophysiology has yet to be determined. We developed a population of autoimmune rats sensitized against their own AP to evaluate the consequences of prolonged AP deficiency on physiological and pathophysiological processes. Natriuresis in response to acute intravenous volume expansion was inhibited in the autoimmune rat, however, natriuresis produced by chronic oral salt loading was not suppressed in these animals. Plasma AP increased threefold in the spontaneously hypertensive rat when evaluated as a function of blood pressure. Immunization of these rats had no effect on the rate of development, magnitude of their developing hypertension, or their daily sodium excretion when compared with nonimmunized controls. Mineralocorticoid escape occurred during desoxycorticosterone acetate administration to rats. The ability of rats to escape from the sodium-retaining effects of this steroid was not affected by prior immunization against AP. These results suggest that AP is an important natriuretic substance in response to acute intravascular volume loading. However, atriopeptin does not appear to be involved in the natriuretic response to chronic intravascular volume loading, blood pressure regulation, or mineralocorticoid escape.

Full text

PDF
1036

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas S. A. Atrial natriuretic factor: a new hormone of cardiac origin. Recent Prog Horm Res. 1986;42:207–249. doi: 10.1016/b978-0-12-571142-5.50009-4. [DOI] [PubMed] [Google Scholar]
  2. Ballermann B. J., Bloch K. D., Seidman J. G., Brenner B. M. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. J Clin Invest. 1986 Sep;78(3):840–843. doi: 10.1172/JCI112650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Currie M. G., Geller D. M., Cole B. R., Boylan J. G., YuSheng W., Holmberg S. W., Needleman P. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science. 1983 Jul 1;221(4605):71–73. doi: 10.1126/science.6857267. [DOI] [PubMed] [Google Scholar]
  4. Currie M. G., Geller D. M., Cole B. R., Siegel N. R., Fok K. F., Adams S. P., Eubanks S. R., Galluppi G. R., Needleman P. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science. 1984 Jan 6;223(4631):67–69. doi: 10.1126/science.6419347. [DOI] [PubMed] [Google Scholar]
  5. Dunn B. R., Ichikawa I., Pfeffer J. M., Troy J. L., Brenner B. M. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res. 1986 Sep;59(3):237–246. doi: 10.1161/01.res.59.3.237. [DOI] [PubMed] [Google Scholar]
  6. Flynn T. G., Davies P. L. The biochemistry and molecular biology of atrial natriuretic factor. Biochem J. 1985 Dec 1;232(2):313–321. doi: 10.1042/bj2320313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flynn T. G., de Bold M. L., de Bold A. J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun. 1983 Dec 28;117(3):859–865. doi: 10.1016/0006-291x(83)91675-3. [DOI] [PubMed] [Google Scholar]
  8. Garcia R., Thibault G., Gutkowska J., Horký K., Hamet P., Cantin M., Genest J. Chronic infusion of low doses of atrial natriuretic factor (ANF Arg 101-Tyr 126) reduces blood pressure in conscious SHR without apparent changes in sodium excretion. Proc Soc Exp Biol Med. 1985 Jul;179(3):396–401. doi: 10.3181/00379727-179-rc1aa. [DOI] [PubMed] [Google Scholar]
  9. Hirth C., Stasch J. P., John A., Kazda S., Morich F., Neuser D., Wohlfeil S. The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):268–275. doi: 10.1097/00005344-198603000-00008. [DOI] [PubMed] [Google Scholar]
  10. Ichimori Y., Kurokawa T., Honda S., Suzuki N., Wakimasu M., Tsukamoto K. Monoclonal antibodies to human interferon-gamma. I. Antibodies to a synthetic carboxyl-terminal peptide. J Immunol Methods. 1985 Jun 12;80(1):55–66. doi: 10.1016/0022-1759(85)90164-4. [DOI] [PubMed] [Google Scholar]
  11. Imada T., Takayanagi R., Inagami T. Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun. 1985 Dec 17;133(2):759–765. doi: 10.1016/0006-291x(85)90969-6. [DOI] [PubMed] [Google Scholar]
  12. Kangawa K., Fukuda A., Minamino N., Matsuo H. Purification and complete amino acid sequence of beta-rat atrial natriuretic polypeptide (beta-rANP) of 5,000 daltons. Biochem Biophys Res Commun. 1984 Mar 30;119(3):933–940. doi: 10.1016/0006-291x(84)90863-5. [DOI] [PubMed] [Google Scholar]
  13. Katsube N., Schwartz D., Needleman P. Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem Biophys Res Commun. 1985 Dec 31;133(3):937–944. doi: 10.1016/0006-291x(85)91226-4. [DOI] [PubMed] [Google Scholar]
  14. Lang R. E., Thölken H., Ganten D., Luft F. C., Ruskoaho H., Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985 Mar 21;314(6008):264–266. doi: 10.1038/314264a0. [DOI] [PubMed] [Google Scholar]
  15. Manning P. T., Schwartz D., Katsube N. C., Holmberg S. W., Needleman P. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science. 1985 Jul 26;229(4711):395–397. doi: 10.1126/science.2990050. [DOI] [PubMed] [Google Scholar]
  16. McLaughlin L. L., Wei Y. F., Stockmann P. T., Leahy K. M., Needleman P., Grassi J., Pradelles P. Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun. 1987 Apr 14;144(1):469–476. doi: 10.1016/s0006-291x(87)80533-8. [DOI] [PubMed] [Google Scholar]
  17. Mulrow P. J., Forman B. H. The tissue effects of mineralocorticoids. Am J Med. 1972 Nov;53(5):561–572. doi: 10.1016/0002-9343(72)90153-2. [DOI] [PubMed] [Google Scholar]
  18. Naruse M., Obana K., Naruse K., Sugino N., Demura H., Shizume K., Inagami T. Antisera to atrial natriuretic factor reduces urinary sodium excretion and increases plasma renin activity in rats. Biochem Biophys Res Commun. 1985 Nov 15;132(3):954–960. doi: 10.1016/0006-291x(85)91900-x. [DOI] [PubMed] [Google Scholar]
  19. Needleman P., Greenwald J. E. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med. 1986 Mar 27;314(13):828–834. doi: 10.1056/NEJM198603273141306. [DOI] [PubMed] [Google Scholar]
  20. Neuser D., Bellemann P. Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells. FEBS Lett. 1986 Dec 15;209(2):347–351. doi: 10.1016/0014-5793(86)81140-1. [DOI] [PubMed] [Google Scholar]
  21. Schwartz D., Geller D. M., Manning P. T., Siegel N. R., Fok K. F., Smith C. E., Needleman P. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science. 1985 Jul 26;229(4711):397–400. doi: 10.1126/science.3160114. [DOI] [PubMed] [Google Scholar]
  22. Tanaka I., Misono K. S., Inagami T. Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem Biophys Res Commun. 1984 Oct 30;124(2):663–668. doi: 10.1016/0006-291x(84)91606-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES